Acker M A
Department of Surgery, University of Pennsylvania Medical Center, Philadelphia 19104, USA.
Ann Thorac Surg. 2001 Mar;71(3 Suppl):S73-6; discussion S82-5. doi: 10.1016/s0003-4975(00)02628-x.
This report provides a review of mechanical circulatory support for patients in cardiogenic shock secondary to acute/fulminant myocarditis. Experience and outcomes with extracorporeal membrane oxygenation, left ventricular assist device support (ABIOMED, Thoratec, Thermo Cardiosystems, Novacor), and biventricular ventricular assist device support (ABIOMED, Thoratec) are described. Patients in cardiogenic shock secondary to acute myocarditis in its fulminant presentation can recover, surprisingly with normal cardiac function. An aggressive approach to the use of mechanical support is strongly justified. Survival, either by bridge to transplant or recovery, should approach 70%. Transplantation can often be avoided.
本报告回顾了急性/暴发性心肌炎继发心源性休克患者的机械循环支持情况。描述了体外膜肺氧合、左心室辅助装置支持（ABIOMED、Thoratec、Thermo Cardiosystems、Novacor）和双心室辅助装置支持（ABIOMED、Thoratec）的经验及结果。急性暴发性心肌炎继发心源性休克的患者能够康复，令人惊讶的是心脏功能恢复正常。积极使用机械支持的方法是完全合理的。通过过渡到移植或康复实现的生存率应接近70%。通常可以避免进行移植。
